New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Clinical Use of Deferoxamine in Distraction Osteogenesis of Irradiated Bone
Clinical Use of Deferoxamine in Distraction Osteogenesis of Irradiated Bone JOURNAL OF CRANIOFACIAL SURGERY Momeni, A., Rapp, S., Donneys, A., Buchman, S. R., Wan, D. C. 2016; 27 (4): 880-882Abstract
The deleterious effects of radiotherapy, including hypovascularity and hypocellularity, have made distraction of irradiated bones challenging. Animal studies, however, have demonstrated adjunctive measures such as the administration of deferoxamine to significantly improve bone regeneration across irradiated distraction gaps. In this report, the authors demonstrate, for the first time, enhanced bone formation following deferoxamine application in a patient following distraction of a previously irradiated maxilla. Computed tomography imaging of the pterygomaxillary buttress on the side of administration revealed significantly increased bone area and density relative to the contralateral buttress. This is the first presentation of clinical deferoxamine use to promote bone formation following irradiated bone distraction and highlights the promise for this adjunctive measure to make outcomes after distraction of irradiated bone more reliable.
View details for DOI 10.1097/SCS.0000000000002633
View details for Web of Science ID 000378088800052
View details for PubMedID 27171947
View details for PubMedCentralID PMC4902756